Yuge, Hiroki
Okada, Hiroshi
Hamaguchi, Masahide
Kurogi, Kazushiro
Murata, Hiroaki
Ito, Masato
Fukui, Michiaki
Article History
Received: 5 September 2023
Accepted: 30 October 2023
First Online: 8 November 2023
Declarations
:
: This study was approved by the Panasonic Health Insurance Organization's local ethics committee (permission number: 2021–001) and was carried out in conformity with the principles of the Helsinki Declaration.
: Not applicable.
: Hamaguchi M received grants from Ono Pharma Co. Ltd., AstraZeneca K.K., Oishi Kenko inc., Nippon Boehringer Ingelheim Co. Ltd., Yamada Bee Farm. Fukui M received grants from Oishi Kenko inc., Ono Pharma Co. Ltd., Yamada Bee Farm, Kissei Pharma Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sanofi K.K., Daiichi Sankyo Co. Ltd., Astellas Pharma Inc., Kyowa Kirin Co. Ltd., MSD K.K., Sumitomo Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Kowa Pharma Co. Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Taisho Pharma Co., Eli Lilly, Japan, K.K., Terumo Corp., Nippon Chemiphar Co. Ltd., Tejin Pharma Ltd., Abbott Japan Co. Ltd., Medical Co., Johnson & Johnson K.K, TERUMO Co.